NCT00095355View on ClinicalTrials.gov

Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

March 31, 2005

Conditions
Huntington's Disease
Interventions
DRUG

Lithium

DRUG

Divalproex

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00095355 - Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease | Biotech Hunter | Biotech Hunter